Vor Biopharma
Clinical trials sponsored by Vor Biopharma, explained in plain language.
-
New hope for Sjögren's: major trial tests drug to tame overactive immune system
Disease control Recruiting nowThis study is testing an investigational drug called telitacicept to see if it can reduce disease activity and improve symptoms in adults with active primary Sjögren's disease. About 250 participants will receive either the drug or a placebo for 48 weeks to compare effects. The d…
Phase: PHASE3 • Sponsor: Vor Biopharma • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
New drug trial aims to tame debilitating Muscle-Weakening disease
Disease control Recruiting nowThis study is testing an investigational drug called telitacicept to see if it can safely reduce symptoms and improve daily life for adults with generalized myasthenia gravis (gMG), an autoimmune disease that causes severe muscle weakness. About 180 participants will be randomly …
Phase: PHASE3 • Sponsor: Vor Biopharma • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC